Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Jazz Pharmaceuticals plc (JAZZ)

215.98 +8.15 (+3.92%)
At close: October 30 at 4:00:01 PM EDT
215.98 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade JAZZ on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
4,601,286
4,267,586
4,068,950
3,834,204
3,659,374
Cost of Revenue
532,896
503,296
445,713
435,577
540,517
Gross Profit
4,068,390
3,764,290
3,623,237
3,398,627
3,118,857
Operating Expense
3,052,068
3,246,668
2,896,607
2,801,047
2,606,589
Operating Income
1,016,322
517,622
726,630
597,580
512,268
Net Non Operating Interest Income Expense
-170,951
-195,051
-238,097
-289,438
-288,242
Other Income Expense
-117,630
-950,430
-18,182
-10,213
-596,810
Pretax Income
727,741
-627,859
470,351
297,929
-372,784
Tax Provision
-213,243
-272,443
-91,429
-119,912
-158,645
Earnings from Equity Interest Net of Tax
-232
-732
-1,660
-3,009
-9,921
Net Income Common Stockholders
940,752
-356,148
560,120
414,832
-224,060
Average Dilution Earnings
--
0
10,762
24,876
0
Diluted NI Available to Com Stockholders
940,752
-356,148
570,882
439,708
-224,060
Basic EPS
15.21
-5.84
9.06
6.55
-3.58
Diluted EPS
14.61
-5.84
8.65
6.10
-3.58
Basic Average Shares
61,681
60,981
61,838
63,291
62,539
Diluted Average Shares
64,331
60,981
66,007
72,066
62,539
Total Operating Income as Reported
896,860
-430,240
716,630
578,580
-65,528
Total Expenses
3,584,964
3,749,964
3,342,320
3,236,624
3,147,106
Net Income from Continuing & Discontinued Operation
940,752
-356,148
560,120
414,832
-224,060
Normalized Income
1,011,330
351,257.05
573,641.95
422,413.11
218,713.34
Interest Expense
170,951
195,051
238,097
289,438
288,242
Net Interest Income
-170,951
-195,051
-238,097
-289,438
-288,242
EBIT
898,692
-432,808
708,448
587,367
-84,542
EBITDA
1,616,689
263,489
1,368,515
1,226,063
544,929
Reconciled Cost of Revenue
495,360
461,660
412,959
405,165
510,215
Reconciled Depreciation
717,997
696,297
660,067
638,696
629,471
Net Income from Continuing Operation Net Minority Interest
940,752
-356,148
560,120
414,832
-224,060
Total Unusual Items Excluding Goodwill
-117,630
-950,430
-18,182
-10,213
-596,810
Total Unusual Items
-117,630
-950,430
-18,182
-10,213
-596,810
Normalized EBITDA
1,734,319
1,213,919
1,386,697
1,236,276
1,141,739
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-47,052
-243,024.95
-4,660.05
-2,631.89
-154,036.66
12/31/2022 - 6/1/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: